Quest PharmaTech Inc.

780-448-1400

  • Home
  • Technology
  • Officers & Directors
  • News Releases
  • Financials & MD&A
  • Contact Us
  • More
    • Home
    • Technology
    • Officers & Directors
    • News Releases
    • Financials & MD&A
    • Contact Us

780-448-1400

Quest PharmaTech Inc.
  • Home
  • Technology
  • Officers & Directors
  • News Releases
  • Financials & MD&A
  • Contact Us

Financial & MD&A

Fiscal 2025

PDF Document – Financial Statements
Consolidated Financial Statements
9 months ended Oct 31, 2024


PDF Document – Management Discussion and Analysis
9 months ended Oct 31, 2024


PDF Document – Financial Statements
Consolidated Financial Statements
6 months ended Jul 31, 2024


PDF Document – Management Discussion and Analysis
6 months ended Jul 31, 2024


PDF Document – Financial Statements
Consolidated Financial Statements
3 months ended Apr 30, 2024


PDF Document – Management Discussion and Analysis
3 months ended Apr 30, 2024

Fiscal 2024

 

PDF Document – Consolidated Financial Statements
January 31, 2024


PDF Document – Management Discussion and Analysis
January 31, 2024


PDF Document – Financial Statements restated
Consolidated Financial Statements
9 months ended Oct 31, 2023 restated


PDF Document – Management Discussion and Analysis restated
9 months ended Oct 31, 2023 restated


PDF Document – Financial Statements
Consolidated Financial Statements
9 months ended Oct 31, 2023


PDF Document – Management Discussion and Analysis
9 months ended Oct 31, 2023


PDF Document – Financial Statements restated
Consolidated Financial Statements
6 months ended Jul 31, 2023 restated


PDF Document – Management Discussion and Analysis restated
6 months ended Jul 31, 2023 restated


PDF Document – Financial Statements
Consolidated Financial Statements
6 months ended Jul 31, 2023


PDF Document – Management Discussion and Analysis
6 months ended Jul 31, 2023


PDF Document – Financial Statements restated
Consolidated Financial Statements
3 months ended Apr 30, 2023 restated


PDF Document – Management Discussion and Analysis restated
3 months ended Apr 30, 2023 restated


PDF Document – Financial Statements
Consolidated Financial Statements
3 months ended Apr 30, 2023


PDF Document – Management Discussion and Analysis
3 months ended Apr 30, 2023


Copyright © 2024 Quest PharmaTech Inc. - All Rights Reserved.

Powered by GoDaddy

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept